Agios Pharma (AGIO) Misses Q4 EPS by 18c

Agios Pharma (NASDAQ: AGIO) reported Q4 EPS of ($0.76), $0.18 worse than the analyst estimate of ($0.58). Revenue for the quarter came in at $14.64 million versus the consensus estimate of $10.94 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• 'We expect salesforce.com (CRM) to capture a meaningful share of next-gen agentic workflows': Cantor
• Deere shares climb as fiscal Q3 earnings and revenue top estimates